Erectile dysfunction: A model for men's health

Journal of Men's Health and Gender

Volumn 1, Issue 2-3, 2004, Pages 255-258

  Kirby, Michael ^a  

^a The Surgery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; COMPUTER; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISTRESS SYNDROME; DRUG TOLERABILITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOCARDIOGRAPHY; ERECTILE DYSFUNCTION; GUILT; HEALTH CARE PERSONNEL; HEART DISEASE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MODEL; NURSING; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REVIEW; RISK FACTOR; SELF ESTEEM; SEXUAL BEHAVIOR; SMOKING; SYMPTOM; UNITED KINGDOM;

EID: 16844376139     PISSN: 15718913     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmhg.2004.07.015     Document Type: Review

References (22)

1. Riley A, Riley E. Behavioural and clinical findings in couples where the man presents with erectile disorder: a retrospective study. Int J Clin Pract 2000;54:220-4.
2. Wagner G, Saenz de Tejada I. Update onmale erectile dysfunction. BMJ 1998;316:678-82.
3. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
4. Wagner TH, Patrick DL, Mckenna SP, Froese PS. Cross-cultural development of a quality of life measure for men with erection difficulties. Qual Life Res 1996;5:443-9.
5. 1 for erectile dysfunction. J Urol 1996;156:80-1.
6. Balon R, Yeragini VK, Pohi R, Ramesh C. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry1993;54:209-12.
7. Waldinger MD, Olivier B. Selective serotonin reuptake inhibitor-induced dysfunction: clinical and research considerations. Int J Clin Psychopharmacol 1998;13:S27-33.
8. Wilke RJ, Yen W, Parkerson Jr GR et al. et al. Quality of life effects of alprostadil therapy for erectile dysfunction: results of a trial in Europe and South Africa. J Urol 1997;157:2124-8.
9. Boolell M, Allen MJ, Ballard SA, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996;8:47-52.
10. NIH Consensus Development Panel on Impotence. JAMA 1990;270:83-90.
11. Curkendall SM, Jones JK, Glasser D, et al. Incidence of medically detected erectile dysfunction and related diseases before and after Viagra (sildenafil citrate). Eur Urol 2001;37(Suppl 2):81.
12. Cummings MH, et al. Erectile dysfunction in patients with diabetes. Hosp Med 1999;60(9):638-44.
13. Sullivan ME, Thompson CS, Dashwod MR, et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cadiovasc Res 1999;43:658-65.
14. Greenstein A, Chen J, Miller H, et al. Does severity of ischaemic coronary disease correlate with erectile function? Int J Impot Res 1997;9:123-6.
15. National Service Framework for Coronary Heart Disease, Standards 3 and 4; 23.
16. Rakhit RD, Marber MS. Nitric oxide: and emerging role in cardio protection? Heart 2002;86:368-72.
17. Department of Health. Health minister to announce new plans to improve men's health: Yvette Cooper sets out action to tackle gender inequalities. London: DoH website, ref 2000/0191.
18. Health Service Circular (HSC 1999/148); Health Service Circular (HSC1999/177).
19. Jackson G, et al. A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int J Clin Pract 1999;53(6):444-51.
20. Coronary Heart Disease Statistics. British Heart Foundation; 1997. p. 1-25.
21. Philips AN, Wannamether SG, Walter M, et al. Life expectancy in men who have never smoked and those who have smoked continuously: 15 year follow up of large cohort of middle aged British men. BMJ 1996;313:907-8.
22. Bortolotti A, et al. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997;20:323-34.